Miljöpåverkan
Rimegepant
Miljörisk:
Användning av rimegepant har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning:
Rimegepant bryts ned långsamt i miljön.
Bioackumulering:
Rimegepant har låg potential att bioackumuleras.
Läs mer
Detaljerad miljöinformation
Detailed background information
Physical properties3,4,5
Solubility at pH 4.7: 2 169 000 µg/L
Solubility at pH 8.6: 62 500 µg/L
pKa: 2.1, 6.5 & 9.8
Molecular weight: 534.57 Da
Environmental Risk Classification
Predicted Environmental Concentration (PEC)
PEC is calculated according to the following formula:
PEC (μg/L) = (A×109×(100-R))/(365×P×V×D×100) = 1.37×10-6×A(100-R)
PEC = 9.93×10-5 μg/L
Where:
A = |
0.75 kg (estimated total sold amount API in Sweden year 2024). |
R = |
3.4% removal rate due to loss by adsorption to sludge particles as calculated in the OECD 106 study |
P = |
number of inhabitants in Sweden = 10×106 |
V (L/day) = |
wastewater volume per capita and day = 200 (ECHA default)1 |
D = |
factor for wastewater dilution by surface water flow = 10 (ECHA default)1 |
Predicted No Effect Concentration (PNEC)
Ecotoxicological studies
Activated sludge microorgansims (guideline OECD 209)6
NOEC (respiration inhibition) = 100 000 µg/L
EC10 (respiration inhibition) = 104 000 μg/L
EC20 (respiration inhibition) = 137 000 μg/L
EC50 (respiration inhibition) = > 1000 000 μg/L
Green alga (Raphidocelis subcapitata) (guideline OECD 201)7
NOEC 72 h (growth rate, chronic toxicity) = 280 μg/L
EC10 72 h (growth rate, chronic toxicity) = 26 000 μg/L
EC20 72 h (growth rate, chronic toxicity) = 29 000 μg/L
EC50 72 h (growth rate, chronic toxicity) = 37 000 μg/L
Daphnids (Daphnia magna) (guideline OECD 211)8
NOEC 21 days (reproduction, chronic toxicity) = 10 000 μg/L
LOEC 21 days (reproduction, chronic toxicity) = >10 000 μg/L
Fathead Minnow (Pimephales promelas) (guideline OECD 210)9
NOEC 32 days (growth (weight), chronic toxicity) = 370 μg/L
LOEC 32 days (growth (weight), chronic toxicity) = 1000 μg/L
EC10 32 days (Growth (weight), chronic toxicity) = 930 μg/L
Midge (Chironomus riparius) (guideline OECD 218)10
NOEC 28 days (emergence ratio, chronic toxicity) = 1011 000 μg/kg
EC10 28 days (emergence ratio, chronic toxicity) = 623 000 μg/kg
NOEC 28 days (development rate, chronic toxicity) = 487 000 μg/kg
EC10 28 days (development rate, chronic toxicity) = >1011 000 μg/kg
Based on the lowest NOEC for the species Raphidocelis subcapitata and using the assessment factor2 of 10, the PNEC is calculated to 280 / 10 = 28 µg/L.
Environmental risk classification (PEC/PNEC ratio)
PEC/PNEC = 9.93×10-5 / 28 = 3.54×10-6, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase ”Use of rimegepant has been considered to result in insignificant environmental risk.”
Adsorption (guideline OECD 106)11
Solid |
Kd (L/Kg) |
Koc (L/Kg) |
Activated sludge (Tilburg) |
307 |
921 |
Activated sludge (Aa and Maas) |
214 |
591 |
HOM soil (Speyer 6S) |
1893 |
122149 |
HOM soil (Speyer 2.2) |
84.1 |
5225 |
LOM soil (Speyer 2.3) |
65.6 |
10087 |
HOM = high organic matter, LOM = low organic matter
Fraction removed on wasted sludge = (0.165×Kd) / [(0.165×Kd) + 1000] where 0.165 represents the grams of sludge wasted per 1000 grams of wastewater treatment plants' aqueous effluent. Based on the lowest sludge Kd of 214, the fraction of rimegepant removed on wasted sludge is = (0.165×214) / [0.165×214 + 1000] = 0.034 = 3.4%.
Degradation
Biotic degradation
Ready degradability (guideline OECD 301B)12
The test was made over a 28-day period and resulted in a 0% biodegradation. Rimegepant is thus not readily biodegradable according to the OECD criteria for ready biodegradability.
Water-sediment transformation simulation (guideline OECD 308)13
Length of study: 100 days
High organic sediment system: Schoonrewoerdse Wiel
Low organic sediment system: Middle Pond
Sediment extraction solvent: 80/20 v/v acetonitrile/water
Supplemental acidic extraction solvents: 0.1 M hydrochloric acid followed by acetone
Supplemental alkaline extraction solvents: 0.1 M sodium hydroxide followed by acetone
The results from the study are shown in the table below.
Data on day 100 at 12 °C |
Schoonrewoerdse Wiel |
Middle Pond |
|
Total system |
|||
Half-life (days) |
88 |
86 |
|
Total 14CO2 (% of AR) |
0.1 |
0.1 |
|
% Parent (% of AR) |
50.5 |
46.7 |
|
Aerobic Water Layer |
|||
Half-life (days) |
8.0 |
1.3 |
|
Parent (% of AR) |
5.5 |
1.5 |
|
Sediment Layer |
|||
Bound/NER (% of AR) |
50.3 |
51.9 |
|
Extractables (% of AR) |
45.2 |
47.7 |
|
Parent (% of AR) |
45.0 |
45.3 |
ND = not detected, NER = non-extractable residues, AR = applied radioactivity
Justification of chosen degradation phrase
As the total system DT50 value (water-sediment transformation simulation, OECD 308) was calculated to <120 days, it corresponds to the degradation phrase ”Rimegepant is slowly degraded in the environment”.
Bioaccumulation
Partitioning coefficient (guideline OECD 107)14
pH |
Log Dow |
5.5 |
1.43 |
7.4 |
1.56 |
8.8 |
1.91 |
Justification of chosen bioaccumulation phrase
Since log Dow < 4 at pH 7.4, rimegepant has low potential for bioaccumulation.
References
-
ECHA, European Chemicals Agency. 2016 Guidance on information requirements and chemical safety assessment chapter R16.
-
ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment chapter R10.
-
Parexel International, Vydura Environmental risk assessment part I. December 2021.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV), Vydura Environmental risk assessment part II. March 2023.
-
Biohaven Pharmaceuticals, Inc., Vydura Module 3.2.S.1 General properties. February 2021.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329866. Activated sludge respiration inhibition test with rimegepant. April 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329858. Freshwater algal growth-inhibition test with rimegepant. August 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329855. Daphnia magna, reproduction test with rimegepant (semi-static). December 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329861. Fish early-life stage toxicity test with rimegepant (flow-through). December 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329875. Sediment-water chironomid toxicity test using sediment spiked with rimegepant. June 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329848. Adsorption/desorption of 14C-labeled rimegepant on three soils and two sludges. October 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329849. Determination of ’ready’ biodegradability: Carbon dioxide (CO2) evolution test (modified Sturm test) of rimegepant. April 2022.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report 20329850. Aerobic transformation of rimegepant in aquatic sediment systems. January 2023.
-
Biohaven Pharmaceuticals, Inc. (Charles River Laboratories Den Bosch BV) study report N21062. Determination of distribution coefficient (Log D5.5, Log D7.4 & Log D 8.8) of BHV-3000 by shake-flask method. January 2022.